ARTICLE
8 November 2018

Using Patents To Raise Finance - Dehns And Green Biologics (Video)

D
Dehns

Contributor

Founded in 1920, Dehns is one of Europe’s largest full service intellectual property firms, with offices in London, Munich, Oslo, Oxford, Bristol, Brighton, Manchester and Birmingham.

In addition to obtaining patent, trade mark and design protection around the world, our services also extend to IP management consulting and dispute resolution. Dehns attorneys have expertise in a wide range of technologies across the engineering, chemistry and biotechnology sectors.

Our clients include private inventors, universities and research institutions, start-ups and SMEs as well as large multinational corporations. We are firmly focussed on delivering clear advice and valuable results at a competitive cost.

Dehns’ straightforward, business-oriented approach combined with technical excellence has made us leaders in our field and we are proud of our top tier rankings.

Dehns has been working with Green Biologics since 2006, when the company was just Dr Green (the founder) and five scientists.
United Kingdom Intellectual Property

Dehns has been working with Green Biologics since 2006, when the company was just Dr Green (the founder) and five scientists. The relationship started when Dehns Partner, Philip Webber, met Dr Green at an industry event. Following further meetings, Philip was asked to draft and file Green Biologics's first patent applications relating to the genetic engineering of bacteria to make butanol.

Watch our short video on how Dehns has assisted Green Biologics in using their IP to leverage finance.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More